Nothing Special   »   [go: up one dir, main page]

BE890574A - Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant - Google Patents

Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant

Info

Publication number
BE890574A
BE890574A BE0/206126A BE206126A BE890574A BE 890574 A BE890574 A BE 890574A BE 0/206126 A BE0/206126 A BE 0/206126A BE 206126 A BE206126 A BE 206126A BE 890574 A BE890574 A BE 890574A
Authority
BE
Belgium
Prior art keywords
aminoalcoyl
furanne
derivative
preparation
pharmaceutical composition
Prior art date
Application number
BE0/206126A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10516407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE890574(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of BE890574A publication Critical patent/BE890574A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
BE0/206126A 1980-10-01 1981-10-01 Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant BE890574A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8031634 1980-10-01

Publications (1)

Publication Number Publication Date
BE890574A true BE890574A (fr) 1982-04-01

Family

ID=10516407

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/206126A BE890574A (fr) 1980-10-01 1981-10-01 Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant

Country Status (29)

Country Link
US (2) US4521431A (fr)
JP (1) JPS5791983A (fr)
KR (1) KR870001431B1 (fr)
AT (1) AT389696B (fr)
AU (1) AU549119B2 (fr)
BE (1) BE890574A (fr)
CA (1) CA1202638A (fr)
CH (1) CH652122A5 (fr)
CZ (1) CZ280885B6 (fr)
DE (1) DE3139134A1 (fr)
DK (2) DK167794B1 (fr)
ES (1) ES505951A0 (fr)
FR (1) FR2491067A1 (fr)
GR (1) GR72499B (fr)
HK (1) HK97985A (fr)
IE (1) IE51604B1 (fr)
IL (1) IL63968A (fr)
IT (1) IT1143237B (fr)
KE (1) KE3549A (fr)
LU (1) LU83661A1 (fr)
MY (1) MY8500747A (fr)
NL (1) NL8104482A (fr)
NZ (1) NZ198522A (fr)
PH (2) PH19489A (fr)
PT (1) PT73744B (fr)
SE (1) SE453500B (fr)
SK (1) SK277922B6 (fr)
ZA (1) ZA816809B (fr)
ZW (1) ZW24481A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT389873B (de) * 1983-07-15 1990-02-12 Richter Gedeon Vegyeszet Verfahren zur herstellung des 1-(2-(5-/

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
SE8704436D0 (sv) * 1987-11-13 1987-11-13 Pm Konsult Handelsbolag Anvendning av antisekretoriska substanser for nya indikationer
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
US5169864A (en) * 1991-11-15 1992-12-08 Baxter International Inc. Unbuffered premixed ranitidine formulation
CN1048984C (zh) * 1991-12-20 2000-02-02 多坎化学有限公司 晶形1呋喃硝胺氢氯化物的制备
US5338871A (en) * 1991-12-20 1994-08-16 Torcan Chemical Ltd. Preparation of form 1 ranitidine hydrochloride
DK0690864T3 (da) * 1993-03-12 2001-09-17 Upjohn Co Krystallinsk ceftiofur på fri syreform
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
CA2120874E (fr) * 1994-04-08 2002-01-08 Keshava Murthy Forme de la ranitidine de forme 1
US5670671A (en) * 1994-04-08 1997-09-23 Brantford Chemicals Inc. Process for the production of an improved form of form 1 ranitidine
CN1147253A (zh) 1994-04-15 1997-04-09 法玛西雅厄普约翰公司 新晶型的1-[5-甲亚磺酰氨基吲哚基-2-羰基]-4-[3-(1-甲基乙基氨基)-2-吡啶基]哌嗪
NZ272054A (en) * 1994-05-13 1996-05-28 Ranbaxy Lab Ltd Process for producing form 1 ranitidine hydrochloride
IN181699B (fr) * 1994-05-13 1998-09-05 Ranbaxy Lab Ltd
IN181698B (fr) * 1994-05-13 1998-09-05 Ranbaxy Lab Ltd
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
HU227676B1 (en) * 1994-05-18 2011-11-28 Aventisub Ii Inc Process for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
ES2122387T3 (es) 1994-06-24 1998-12-16 Ranbaxy Lab Ltd Procedimiento para la preparacion de la forma 1 del clorhidrato de ranitidina.
NZ297590A (en) * 1994-11-18 1999-06-29 Upjohn Co Physically stable solid form of a fluoroquinolone
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
US5663381A (en) * 1995-04-21 1997-09-02 Hexal Pharmaceuticals, Inc. Process for preparing form 1 ranitidine hydrochloride
US5686588A (en) * 1995-08-16 1997-11-11 Yoo; Seo Hong Amine acid salt compounds and process for the production thereof
AU1972097A (en) * 1996-03-25 1997-10-17 Hoechst Marion Roussel, Inc. Process for the preparation of form 1 ranitidine hydrochloride
PT987256E (pt) * 1997-08-08 2002-03-28 Aventis Pharma Gmbh Forma cristalina da n-(4-trifluorometilfenil)-5-metil-isoxazol-4-carboxamida
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
IT1317858B1 (it) 2000-02-29 2003-07-15 Pharmexcel S R L Allomorfo del cloridrato dell'isomero z di derivato dialchilamminofurano, procedimento per la sua produzione e composizione
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
US6569887B2 (en) * 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
US20060173064A1 (en) * 2001-08-24 2006-08-03 Lippa Arnold S (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
TW200409746A (en) * 2002-07-26 2004-06-16 Theravance Inc Crystalline β2 adrenergic receptor agonist
US20080081834A1 (en) 2002-07-31 2008-04-03 Lippa Arnold S Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
MXPA05004873A (es) * 2002-11-08 2005-12-05 Dov Pharmaceuticals Inc Polimorfos de clorhidrato de bicifadina.
TW200510277A (en) * 2003-05-27 2005-03-16 Theravance Inc Crystalline form of β2-adrenergic receptor agonist
US7384557B2 (en) * 2003-07-14 2008-06-10 Applied Ambient Extraction Process Consultants, Llc Method and apparatus for removing solute from a solid solute-bearing product
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
US20070043100A1 (en) * 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
US20060100263A1 (en) * 2004-11-05 2006-05-11 Anthony Basile Antipyretic compositions and methods
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
BRPI0613943B1 (pt) 2005-07-27 2021-06-22 Otsuka America Pharmaceutical, Inc Composto, composição farmacêutica o compreendendo, usos de um composto e de uma composição farmacêutica, bem como composição neurobiologicamente ativa
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
US20080045725A1 (en) 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
US7662980B2 (en) * 2006-10-20 2010-02-16 Scinopharm Singapore Pte Ltd. Crystalline forms of docetaxel and process for preparation thereof
US8138377B2 (en) 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
US9133159B2 (en) 2007-06-06 2015-09-15 Neurovance, Inc. 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
EP2167083B1 (fr) * 2007-06-06 2015-10-28 Euthymics Bioscience, Inc. 1- hétéroaryl-3-azabicyclo[3.1.0]hexanes, leurs méthodes de préparation et leur utilisation comme médicaments
TW201011043A (en) * 2008-06-20 2010-03-16 Chugai Pharmaceutical Co Ltd Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
JP5998933B2 (ja) * 2011-06-30 2016-09-28 東レ株式会社 グリシン誘導体の結晶及びその医薬用途
US20140206740A1 (en) 2011-07-30 2014-07-24 Neurovance, Inc. Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
CN106432147B (zh) * 2015-05-26 2018-04-17 烟台市华文欣欣医药科技有限公司 一种制备治疗胃病的药物盐酸雷尼替丁化合物的方法
CN105030694A (zh) * 2015-08-04 2015-11-11 青岛蓝盛洋医药生物科技有限责任公司 一种治疗胃溃疡的药物盐酸雷尼替丁组合物干混悬剂
CN104971053A (zh) * 2015-08-05 2015-10-14 青岛蓝盛洋医药生物科技有限责任公司 一种治疗消化系统疾病的药物盐酸雷尼替丁组合物片剂
CN105055331A (zh) * 2015-08-31 2015-11-18 青岛蓝盛洋医药生物科技有限责任公司 一种治疗消化性溃疡的药物盐酸雷尼替丁组合物颗粒剂
WO2021079183A1 (fr) * 2019-10-21 2021-04-29 Sms Pharmaceuticals Limited Forme cristalline 2 du chlorhydrate de ranitidine exempte de solvant alcool isopropylique et exempte d'impureté de nitrosamine (ndma)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT389873B (de) * 1983-07-15 1990-02-12 Richter Gedeon Vegyeszet Verfahren zur herstellung des 1-(2-(5-/

Also Published As

Publication number Publication date
MY8500747A (en) 1985-12-31
KR870001431B1 (ko) 1987-08-06
NL8104482A (nl) 1982-05-03
SK403591A3 (en) 1995-08-09
PH21761A (en) 1988-02-18
JPH0443070B2 (fr) 1992-07-15
AU549119B2 (en) 1986-01-16
SK277922B6 (en) 1995-08-09
AU7595581A (en) 1982-04-08
KR830007070A (ko) 1983-10-14
PT73744B (en) 1983-10-31
IE51604B1 (en) 1987-01-21
IE812287L (en) 1982-04-01
JPS5791983A (en) 1982-06-08
US4521431A (en) 1985-06-04
CZ280885B6 (cs) 1996-04-17
IT1143237B (it) 1986-10-22
DK167794B1 (da) 1993-12-13
PT73744A (en) 1981-10-01
US4672133A (en) 1987-06-09
NZ198522A (en) 1985-07-12
DK167923B1 (da) 1994-01-03
SE8105812L (sv) 1982-04-02
PH19489A (en) 1986-05-14
CA1202638A (fr) 1986-04-01
DE3139134C2 (fr) 1990-04-19
DK33792D0 (da) 1992-03-12
DK436281A (da) 1982-04-02
IL63968A0 (en) 1981-12-31
DE3139134A1 (de) 1982-05-19
FR2491067A1 (fr) 1982-04-02
CZ403591A3 (en) 1994-01-19
ES8301954A1 (es) 1983-01-01
ZA816809B (en) 1983-05-25
HK97985A (en) 1985-12-13
FR2491067B1 (fr) 1984-09-07
GR72499B (fr) 1983-11-15
SE453500B (sv) 1988-02-08
ATA422281A (de) 1989-06-15
CH652122A5 (fr) 1985-10-31
AT389696B (de) 1990-01-10
IT8149407A0 (it) 1981-10-01
DK33792A (da) 1992-03-12
ZW24481A1 (en) 1983-04-27
IL63968A (en) 1985-10-31
ES505951A0 (es) 1983-01-01
LU83661A1 (fr) 1983-06-08
KE3549A (en) 1985-08-16

Similar Documents

Publication Publication Date Title
BE890574A (fr) Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant
FR2567131B1 (fr) Nouveaux derives de ganglioside, procede pour leur obtention et composition pharmaceutique les contenant
FR2518095B1 (fr) Nouveaux l-oxa-, thia- et aza-spirocyclo-benzene-acetamides et benzamides, leur procede de preparation et composition pharmaceutique les contenant
FR2505835B1 (fr) Nouvelles 1,2-diaminocyclobutene-3,4-diones, leur procede de preparation et composition pharmaceutique les contenant
FR2569402B1 (fr) Derives d'acide 3,5-pyridine-dicarboxylique, procede pour leur preparation et composition pharmaceutique les contenant
MC1390A1 (fr) Derives de pyrazolopyridazine,procede pour leur preparation et compositions pharmaceutiques les contenant
FR2495154B1 (fr) 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant
BE861964A (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
FR2490493B1 (fr) Composition pharmaceutique ou alimentaire contenant de l'a -cetoglutarate de pyridoxine, procede pour sa preparation
LU81132A1 (fr) 2-(2-thenoylthio)-propionylglycine,procede pour sa preparation et compositions pharmaceutiques la contenant
FR2569702B1 (fr) Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation
BE892552A (fr) Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides
FR2567519B1 (fr) Nouvelles isoindolinyl-alcoyl-piperazines, compositions pharmaceutiques les contenant, et leur procede de preparation
BE894927A (fr) Derives de l'ergoline, procede pour leur preparation et medicaments les contenant
FR2600061B1 (fr) Derives d'indole, composition pharmaceutique les contenant et procede pour leur preparation
FR2563519B1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2528422B1 (fr) Nouveaux derives du 1,2,3,4-tetrahydronaphtalene, procede pour leur preparation et composition pharmaceutique contenant ces derives
MC1549A1 (fr) Anthracycline-glycosides,procede pour leur preparation et medicaments les contenant
FR2513994B1 (fr) Tripeptides anorexigenes, procede pour leur preparation et compositions pharmaceutiques les contenant
PT77767B (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
BE896629A (fr) Derives d'acide carbazique, procede pour leur preparation et compositions les contenant.
BE894729A (fr) Derives du phosphoramide, procede pour leur preparation et medicaments en contenant
FR2547821B1 (fr) Sel de 2-piperazinopyrimidine, procede pour sa preparation et compositions pharmaceutiques en contenant
FR2517672B1 (fr) Thioalcanoyl-carnitines, procede pour leur preparation et composition pharmaceutique les contenant
FR2513542B1 (fr) Composition d'engrais, procede pour sa preparation et ses utilisations

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: GLAXO GROUP LTD

Effective date: 20011001